Kim Y - Search Results

1

Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.

Yun CY, Roh E, Kim SH, Han J, Lee J, Jung DE, Kim GH, Jung SH, Cho WJ, Han SB, Kim Y. Yun CY, et al. Among authors: kim gh, kim sh, kim y. Theranostics. 2020 Jan 1;10(1):340-352. doi: 10.7150/thno.39066. eCollection 2020. Theranostics. 2020. PMID: 31903124 Free PMC article.

2

Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response.

Kim BH, Chung EY, Ryu JC, Jung SH, Min KR, Kim Y. Kim BH, et al. Among authors: kim y. Arch Pharm Res. 2003 Apr;26(4):306-11. doi: 10.1007/BF02976960. Arch Pharm Res. 2003. PMID: 12735689

3

Structural requirement of isoflavonones for the inhibitory activity of interleukin-5.

Jung SH, Cho SH, Dang TH, Lee JH, Ju JH, Kim MK, Lee SH, Ryu JC, Kim Y. Jung SH, et al. Among authors: kim y, kim mk. Eur J Med Chem. 2003 May;38(5):537-45. doi: 10.1016/s0223-5234(03)00064-3. Eur J Med Chem. 2003. PMID: 12767605

4

Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation.

Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, Hong JT, Min KR, Kim Y. Shin HM, et al. Among authors: kim bh, kim ys, kim mh, kim y. FEBS Lett. 2004 Jul 30;571(1-3):50-4. doi: 10.1016/j.febslet.2004.06.056. FEBS Lett. 2004. PMID: 15280016 Free article.

5

Anti-inflammatory effects of N1-benzyl-4-methylbenzene-1,2-diamine (JSH-21) analogs on nitric oxide production and nuclear factor-kappa B transcriptional activity in lipopolysaccharide-stimulated macrophages RAW 264.7.

Min KR, Shin HM, Lee JH, Kim BH, Chung EY, Jung SH, Kim Y. Min KR, et al. Among authors: kim bh, kim y. Arch Pharm Res. 2004 Oct;27(10):1053-9. Arch Pharm Res. 2004. PMID: 15554264

6

Anti-inflammatory benzene diamine compound inhibited toll-like receptor 4-mediated inducible nitric oxide synthase expression and nuclear factor-kappa B activation.

Kim BH, Shin HM, Jung SH, Yoon YG, Min KR, Kim Y. Kim BH, et al. Among authors: kim y. Biol Pharm Bull. 2005 May;28(5):908-11. doi: 10.1248/bpb.28.908. Biol Pharm Bull. 2005. PMID: 15863904 Free article.

7

Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.

Shin HM, Byung Hak Kim, Eun Yong Chung, Jung SH, Yeong Shik Kim, Kyung Rak Min, Kim Y. Shin HM, et al. Among authors: kim y. Eur J Pharmacol. 2005 Oct 3;521(1-3):1-8. doi: 10.1016/j.ejphar.2005.07.013. Epub 2005 Sep 23. Eur J Pharmacol. 2005. PMID: 16183054

8

Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression.

Kim KS, Kim JA, Eom SY, Lee SH, Min KR, Kim Y. Kim KS, et al. Among authors: kim ja, kim y. Pigment Cell Res. 2006 Feb;19(1):90-8. doi: 10.1111/j.1600-0749.2005.00281.x. Pigment Cell Res. 2006. PMID: 16420250

9

Structural requirement of chalcones for the inhibitory activity of interleukin-5.

Yang HM, Shin HR, Cho SH, Bang SC, Song GY, Ju JH, Kim MK, Lee SH, Ryu JC, Kim Y, Jung SH. Yang HM, et al. Among authors: kim y, kim mk. Bioorg Med Chem. 2007 Jan 1;15(1):104-11. doi: 10.1016/j.bmc.2006.10.007. Epub 2006 Oct 10. Bioorg Med Chem. 2007. PMID: 17064909

10

The role of the hydrophobic group on ring A of chalcones in the inhibition of interleukin-5.

Yang HM, Shin HR, Cho SH, Song GY, Lee IJ, Kim MK, Lee SH, Ryu JC, Kim Y, Jung SH. Yang HM, et al. Among authors: kim y, kim mk. Arch Pharm Res. 2006 Nov;29(11):969-76. doi: 10.1007/BF02969280. Arch Pharm Res. 2006. PMID: 17146965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,256 results

Search Page

Filters